Variable

IAE

(n = 40)

IANE

(n = 32)

Χ²/t/U

P^*

Male/Female

26/14

20/12

0.048

0.826

Age/Month

58 (23, 97)

60 (35, 84)

437.000

0.545

Blood biochemical

AST/U·L⁻¹

37 (33, 47)

49 (35, 101)

815.000

0.026

ALT/U·L⁻¹

18 (12, 20)

25 (14, 48)

776.500

0.013

CK/U·L⁻¹

174 (115, 279)

239 (159, 356)

440.000

0.036

CK-MB/U·L⁻¹

15 (9, 26)

19 (12, 33)

347.000

0.105

Cr/umol·L⁻¹

32 (24, 38)

41 (23, 49)

1842.000

0.689

Urea/mmol·L⁻¹

3.39 (3.06, 4.40)

3.78 (3.10, 5.30)

655.000

0.164

LDH/U·L⁻¹

336 (218, 493)

567 (369, 916)

109.500

<0.001

Coagulation

PT/S

14.66 ± 1.08

16.79 ± 5.21

1.514

0.153

TT/S

17.47 ± 1.76

19.58 ± 4.29

1.773

0.096

APTT/S

45.97 ± 14.39

49.45 ± 10.82

0.651

0.522

FIB/g·L⁻¹

3.05 ± 0.88

2.63 ± 0.92

1.444

0.156

Cerebrospinal fluid

CSF leukocyte /10⁶·L⁻¹

3 (1, 4)

4 (1, 6)

326.000

0.094

CSF GLU/mmol·L⁻¹

3.44 (3.20, 3.67)

3.71 (3.17, 4.27)

356.000

0.231

CSF LDH/U·L⁻¹

21 (16, 24)

76 (24, 145)

127.500

<0.001

CSF PRO/g·L⁻¹

0.28 (0.21, 0.39)

0.65 (0.43, 0.98)

147.000

<0.001

The prognosis

Sequelae (%)

14 (35)

17 (53)

2.382

0.123

Died (%)

0 (0)

10 (31)

12.021

0.001